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and beluga whales showed that none 
of these animals were colonized with 
MRSA. Overall, MRSA was isolated 
on >1 occasions from 5 dolphins (n = 
6, 83.3%) and 3 walruses (n = 6, 50%) 
(Table). All strains were indistinguish-
able on PFGE and were consistent 
with the CMRSA2 (USA100) strain. 
They were also spa type t002 and did 
not possess the PVL toxin genes.
This report of MRSA shows 
colonization in several dolphins and 
walruses, with apparent transmis-
sion between species. The direction 
of transmission cannot be determined 
because of the sampling method; how-
ever, a human origin is suspected be-
cause the clone that was isolated is a 
predominant human clone. The failure 
to identify a concurrently colonized 
person does not preclude a human 
source. Since the time MRSA was in-
troduced into the facility is unknown, 
the source of infection may have been 
decolonized by the time of sampling 
or was not sampled. Furthermore, 
park visitors occasionally have con-
tact with these animals so the origin 
could have been from the general pub-
lic. Whether colonization of multiple 
animals was due to repeated instances 
of human-to-animal transmission or 
whether animal-to-animal transmis-
sion may have occurred is not clear. 
For the dolphins, the second scenario 
is most likely, considering the social 
nature of these animals and the in-
ability to isolate colonized dolphins. 
These factors may have resulted in the 
circulation of MRSA among these ani-
mals. Although no water samples were 
obtained for testing, waterborne trans-
mission cannot be dismissed.
Colonization was eliminated 
without antimicrobial agents; how-
ever, long-term (15 months) MRSA 
colonization was found in 1 dolphin. 
With patience and continued use of 
infection control measures, MRSA 
was apparently eradicated from this 
facility without the need for active 
decolonization. This study shows the 
impressive ability of MRSA to colo-
nize diverse animal species and pro-
vides further evidence suggesting that 
interspecies transmission of human 
epidemic clones can occur between 
persons and animals. This study also 
provides evidence suggesting that 
MRSA colonization in many animal 
species can be transient and that appli-
cation of appropriate infection control 
and hygiene measures may be critical 
control tools for the management of 
MRSA in animals.
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Parachlamydia and 
Rhabdochlamydia 
in Premature 
Neonates
To the Editor: New members 
have recently been recognized in the 
order Chlamydiales (1). The family 
Rhabdochlamydiaceae includes R. por-
cellionis (a parasite of Porcellio scab-
er) and R. crassifi cans (a pathogen of 
the cockroach Blatta orientalis) (2,3); 
their pathogenic role in humans has not 
yet been investigated. Parachlamydia 
acanthamoebae and Protochlamydia 
naegleriophila belong to the family 
Parachlamydiaceae (1,4). Increasing 
evidence indicates that these obligate 
intracellular bacteria infecting free-
living amebae may cause respiratory 
diseases in humans (1). Recent fi ndings 
also suggest a role for Parachlamydia 
in miscarriage, stillbirth, and preterm 
labor (5–7). Whether these bacteria 
may contaminate the newborns of in-
fected mothers is unknown.
The aims of this study were to 
1) develop a real-time PCR for de-
tecting Rhabdochlamydia spp. and 2) 
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apply this PCR, and those previously 
described for Parachlamydia and Pro-
tochlamydia (4,8), to respiratory sam-
ples from premature neonates. Using 
the GenBank database (www.ncbi.nlm.
nih.gov), we selected primers RcF (5′-
GACGCTGCGTGAGTGATGA-3′) 
and RcR (5′-CCGGTGCTTCTTT
ACGCAGTA-3′), and probe RcS (5′-6 
carboxyfl uorescein-CTTTCGGGTT-
GTAAAACTCTTTCGCGCA-Black 
Hole Quencher 1-3′), which amplify 
parts of the 16S rRNA encoding gene, 
to specifi cally amplify Rhabdochla-
mydia spp. The 5′-FAM probe (Euro-
gentec, Seraing, Belgium) contained 
locked nucleic acids (underlined) to 
improve specifi city. Reactions were 
performed with 0.2 μM of each primer, 
0.1 μM of probe, and iTaq Supermix 
(Bio-Rad, Rheinach, Switzerland). 
PCR products were detected with ABI 
Prism 7000 (Applied Biosystems, 
Rotkreuz, Switzerland). Inhibition, 
negative PCR mixture, and extraction 
controls were systematically tested.
To enable quantifi cation, a plasmid 
containing the target gene was con-
structed as described (4,9). The analyti-
cal sensitivity of the real-time PCR for 
Rhabdochlamydia spp. was <10 copies 
DNA/μL. No cross-amplifi cation was 
observed when the analytical specifi city 
was tested with human, amebal (Acan-
thamoeba castellanii ATCC 30010), 
and bacterial DNA (online Technical 
Appendix, available from www.cdc.
gov/EID/content/15/12/2072-Techapp.
pdf). Intrarun and interrun reproduc-
ibility were excellent (online Technical 
Appendix).
This PCR and those previously 
described for Parachlamydia and Pro-
tochlamydia (4,8) were retrospectively 
applied to 39 respiratory samples from 
29 neonates admitted in the neonatol-
ogy unit of our institution (median 1 
sample per patient, range 1–4 sample). 
All but 1 patient had a gestational 
age at birth <36 weeks (median 28.6, 
range 24.6–41.2 weeks). Respiratory 
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Table. Characteristics of 29 newborns with positive PCR results for Parachlamydia acanthamoebae or Rhabdochlamydia  spp. and 
controls*
Characteristics Positive PCR result, n = 12 Negative PCR result, n = 17 p value†
Sex, M/F 8 (67)/4 (33) 6 (35)/11 (65) 0.14
Gestational age at birth, wk, median (range) 27 (24–36) 30 (25–41) 0.16
Weight <10th percentile 4 (33) 4 (24) 0.68
Height <10th percentile 3 (25) 6 (35) 0.69
Primary adaptation
 First Apgar score (1 min), median (range) 2.5 (0–7) 8 (2–9) 0.0017
 First 3 Apgar scores,‡ median (range) 18.5 (8–27) 27 (17–29) 0.0023
 Cardiac massage in first 48 h 6 (50) 0 (0) 0.002
 Endotracheal intubation in first 48 h 11 (92) 8 (47) 0.019
Respiratory distress syndrome 11 (92) 14 (82) 0.62
Hyaline membranes disease 9 (75) 8 (47) 0.25
Bradypneic syndrome 7 (58) 11 (65) 1.00
Bronchopulmonary dysplasia 8 (67) 9 (53) 0.70
Amniotic fluid aspiration 1 (8) 3 (18) 0.62
Invasive mechanical ventilation, d, median (range) 12 (2–50) 3 (0–14) 0.005
Endotracheal intubation during hospital stay 12 (100) 11 (65) 0.028
Infectious complications 
 Lung infection 5 (42) 7 (41) 1.00
 Other systemic infection 7 (58) 5 (29) 0.15
Other complications 
 Intraventricular hemorrhage 4 (33) 6 (35) 1.00
 Persistent artery canal 7 (58) 6 (35) 0.27
 Necrotizing enterocolitis 2 (17) 1 (6) 0.55
 Congenital malformations 1 (8) 1 (6) 1.00
Hospitalization
 Stay in neonatology ward, d,§ median (range) 113.5 (9–435) 48 (7–131) 0.003
 Death 3 (25) 0 (0) 0.06
Pregnancy 
 Premature membranes rupture 5 (42) 6 (35) 1.00
 Placental detachment 2 (17) 1 (6) 0.55
 Preeclampsia 4 (33) 2 (12) 0.20
 Systemic infection 7 (58) 9 (53) 1.00
 Cesarean delivery 9 (75) 10 (59) 0.45
*Results are given as no. (%) except as indicated. 
†Fisher exact test and nonparametric Mann-Whitney rank sum test were used for the analysis of proportions and continuous variables, respectively. 
‡Sum of the 3 scores at 1, 5, and 10 min after birth. 
§If survived. 
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distress syndrome was present in 25 
(86%) of these 29 neonates. Samples 
had been drawn a median of 14 days 
(range 1–229 days) after birth, when 
clinically indicated. Results of PCR for 
Parachlamydia, Protochlamydia, and 
Rhabdochlamydia were positive for 9 
(31%), 0 (0%), and 4 (14%) neonates, 
respectively. Positive results were ob-
tained on the fi rst sample drawn after 
birth for all but 2 neonates (initial nega-
tive results). One patient had positive 
PCR results for Parachlamydia and 
Rhabdochlamydia. These 12 newborns 
with positive PCR results for Parachla-
mydia and/or Rhabdochlamydia were 
compared with the 17 who had nega-
tive PCR results (Table).
Newborns with a Chlamydia-relat-
ed organism documented in the respira-
tory tract had a signifi cantly worse pri-
mary adaptation score (Apgar). These 
patients experienced more resuscitation 
maneuvers at birth. Durations of inva-
sive mechanical ventilation and hospi-
tal stay were also longer among them. 
Three newborns died, compared with 
no deaths among the 17 with negative 
PCR results (p = 0.06). Pneumonia 
was documented in 5 of the 12 patients 
with positive Parachlamydia and/or 
Rhabdochlamydia PCR results but was 
concomitant to PCR positivity for only 
3 of them. An alternative etiology was 
documented in all 3 (online Technical 
Appendix).
Parachlamydia and Rhabdochla-
mydia have thus been detected in a 
population of premature neonates. Most 
of these patients had severe respiratory 
distress syndrome, and the role of these 
bacteria as a causal agent of pneumonia 
could not be clearly assessed. The lon-
ger duration of mechanical ventilation 
for newborns with positive PCR results 
may suggest an occult superinfection 
with a Chlamydia-related bacterium 
contributing to the severity of the initial 
respiratory disease.
Our results also raise a ques-
tion about the mode of acquisition of 
these microorganisms. A recent study 
reported a higher seroprevalence of 
Parachlamydia in women experienc-
ing miscarriage (5,6), and DNA of this 
bacterium has been detected in the am-
niotic fl uid of a woman with premature 
delivery (7). Whether neonatal infec-
tion results from a systemic infection 
during pregnancy or an inoculation at 
delivery is unknown. Because of the 
retrospective design of the study, no 
samples from the mothers were avail-
able for additional molecular or sero-
logic analyses. Hospital water supplies 
are an important reservoir of free-liv-
ing amebae and may represent another 
mode of acquisition because patients 
undergoing mechanical ventilation are 
exposed to aerosolized particles (10). 
Simultaneous detection of Parachla-
mydia and Rhabdochlamydia in 2 pa-
tients with initial negative results and 
their simultaneous detection in 1 neo-
nate supports the latter hypothesis.
In conclusion, Parachlamydia 
and Rhabdochlamydia DNA were 
detected in respiratory secretions of 
premature newborns with more severe 
conditions at birth, more mechanical 
ventilation requirements, and a trend 
toward a higher mortality rate. The 
pathogenic role of these Chlamydia-
related bacteria in neonates deserves 
further investigations.
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Porcine Kobuvirus 
in Piglets, Thailand 
To the Editor: To date, the ge-
nus Kobuvirus has consisted of 2 of-
fi cially recognized species, Aichi virus 
and Bovine Kobuvirus (1). Aichi virus 
has been shown to be associated with 
acute gastroenteritis in humans (2–4), 
and bovine kobuvirus has been detect-
ed only in cattle (5,6). Most recently, 
a third candidate species of Kobuvirus 
has been described in pigs by 2 dif-
ferent groups of investigators from 
Hungary and the People’s Republic of 
China (7,8). This new candidate spe-
cies was serendipitously recognized in 
stool specimens from pigs when PCR 
products (≈1,100 bp) were amplifi ed 
by using a primer pair for the detec-
tion of caliciviruses (7).
Nucleotide sequences of these 
nonspecifi c PCR products were simi-
lar to those of the U-1 bovine kobuvi-
rus and Aichi virus A846/88 reference 
strains; sequence identities ranged 
from 73% to 79% at the nucleotide 
level and from 69% to 70% at the 
amino acid (7). The representative 
strain of a new candidate species of 
porcine kobuvirus, S-1-HUN (Por-
cine kobuvirus/swine/S-1-HUN/2007/
Hungary), has been analyzed to deter-
mine its complete genome sequence 
and genetic organization (9). The 
RNA genome of the S-1-HUN strain 
comprises 8,210 nt, with a genome 
organization analogous to that of pi-
cornaviruses. Therefore, this strain is 
tentatively classifi ed as a new species 
of the genus Kobuvirus, and named 
porcine kobuvirus (7,9).
Currently, 2 reports have de-
scribed the epidemiologic feature of 
porcine kobuvirus in healthy piglets. 
Thirty-nine (65%) of 60 stool samples 
collected from pigs in Hungary were 
positive for porcine kobuvirus by re-
verse transcription–PCR (RT-PCR) 
(9). Another report from China found 
that the prevalence of porcine kobuvi-
rus was 30% (97 of 322 piglets) (8). 
These fi ndings suggested that porcine 
kobuvirus infections are common in 
piglets. However, whether this agent 
is associated with particular diseases, 
including gastroenteritis, in piglets 
was not clear.
We conducted an epidemiologic 
survey of porcine kobuvirus and report 
the detection of this virus in the stool 
specimens of piglets with diarrhea. 
Sequence and phylogenetic analyses 
of the porcine kobuvirus strains were 
carried out to determine their evolu-
tionary relationships with kobuvirus 
strains previously reported.
A total of 98 stool specimens were 
collected from piglets with diarrhea 
from 6 farms in Chiang Mai Province, 
Thailand, during 2001–2003. Age of 
the piglets ranged from 7 to 49 days 
old. Porcine kobuvirus was detected 
in fecal specimens by RT-PCR (9). 
The representative strains of porcine 
kobuvirus detected in our study were 
analyzed further by direct sequenc-
ing of their PCR amplicons (216 bp) 
by using BigDye Terminator Cycle 
Sequencing Kit (Applied Biosystems, 
Foster City, CA, USA). Sequences of 
these fragments were compared with 
those of reference strains available in 
the NCBI GenBank database by using 
BLAST server (http://blast.ncbi.nlm.
nih.gov/Blast.cgi). Phylogenetic and 
molecular evolutionary analyses were 
conducted by using MEGA 4 (10). 
Nucleotide sequences of porcine ko-
buvirus strains described in this study 
were deposited in GenBank under ac-
cession nos. GQ152093–GQ152122.
Prevalence of porcine kobuvirus 
was exceptionally high in piglets with 
diarrhea, 99% (97 of 98 specimens). 
Thirty representative strains of por-
cine kobuvirus detected in this study 
were randomly selected, sequenced, 
and analyzed to determine their evolu-
tionary relationships with other kobu-
virus reference strains. The partial 3D 
region among all 30 porcine kobuvi-
rus strains was highly conserved, with 
nucleotide sequence identities >90%. 
In addition, our strains were most 
closely related to 2 porcine kobuvi-
rus reference strains (S-1-HUN and 
Swine/2007/CHN) available in Gen-
Bank, with the nucleotide sequence 
identity ranging from 91.5% to 96.3%. 
Phylogenetic analysis of partial 3D 
nucleotide sequences of our porcine 
kobuvirus strains, together with pub-
lished sequences of porcine kobuvirus 
reference strains (and those of Aichi 
virus and bovine kobuvirus), is shown 
in the Figure. The phylogenetic tree 
confi rmed that all strains we identi-
fi ed belonged to the porcine kobuvi-
rus species and formed a tight cluster 
in a monophyletic branch with the 
other 2 porcine kobuvirus reference 
strains (S-1-HUN and Swine/2007/
CHN). These strains are also distantly 
related to standard strains of Aichi vi-
rus and bovine kobuvirus. Recently, 
18 sequences of partial 3D region of 
the porcine kobuvirus strains detect-
ed in China have been deposited in 
GenBank. Unfortunately, the specifi c 
position of PCR amplifi cation of the 
strains found in China was different 
from that of our strains (8). Therefore, 
the relationship between these strains 
could not be analyzed.
Porcine kobuviruses have previ-
ously been reported only in healthy 
pigs (7–9). In our study, the excep-
tionally high prevalence of porcine 
kobuviruses (99%) has been observed 
in piglets with acute gastroenteritis; 
those samples were negative for rotavi-
rus infection as determined previously 
by RT-PCR. However, associations of 
this agent with enteric diseases in pigs 
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